Advertisement

Topics

Updated review confirms efficacy and safety of most standard treatments for latent tuberculosis infection

13:00 EDT 31 Jul 2017 | Medical Xpress

Robust evidence confirms that most standard treatment regimens currently recommended by the World Health Organization and the Centers for Disease Control and Prevention for latent tuberculosis infection (LTBI), including rifampicin-isoniazid for 3 months, are safe and effective for preventing active TB. The evidence for rifapentine-isoniazid for 3 months with a reduced pill burden is improving, but more evidence is still needed.

Original Article: Updated review confirms efficacy and safety of most standard treatments for latent tuberculosis infection

NEXT ARTICLE

More From BioPortfolio on "Updated review confirms efficacy and safety of most standard treatments for latent tuberculosis infection"

Quick Search
Advertisement
 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...